Pallet Trucks
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Canine Arthritis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Non-Steroidal Anti-Inflammatory Drugs 1.2.3 Opioids 1.3 Market by Application 1.3.1 Global Canine Arthritis Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Veterinary Hospitals and Clinics 1.3.3 Drug Stores 1.3.4 E-commerce 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Canine Arthritis Treatment Market Perspective (2017-2028) 2.2 Canine Arthritis Treatment Growth Trends by Region 2.2.1 Canine Arthritis Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Canine Arthritis Treatment Historic Market Size by Region (2017-2022) 2.2.3 Canine Arthritis Treatment Forecasted Market Size by Region (2023-2028) 2.3 Canine Arthritis Treatment Market Dynamics 2.3.1 Canine Arthritis Treatment Industry Trends 2.3.2 Canine Arthritis Treatment Market Drivers 2.3.3 Canine Arthritis Treatment Market Challenges 2.3.4 Canine Arthritis Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Canine Arthritis Treatment Players by Revenue 3.1.1 Global Top Canine Arthritis Treatment Players by Revenue (2017-2022) 3.1.2 Global Canine Arthritis Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Canine Arthritis Treatment Revenue 3.4 Global Canine Arthritis Treatment Market Concentration Ratio 3.4.1 Global Canine Arthritis Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Treatment Revenue in 2021 3.5 Canine Arthritis Treatment Key Players Head office and Area Served 3.6 Key Players Canine Arthritis Treatment Product Solution and Service 3.7 Date of Enter into Canine Arthritis Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Canine Arthritis Treatment Breakdown Data by Type 4.1 Global Canine Arthritis Treatment Historic Market Size by Type (2017-2022) 4.2 Global Canine Arthritis Treatment Forecasted Market Size by Type (2023-2028) 5 Canine Arthritis Treatment Breakdown Data by Application 5.1 Global Canine Arthritis Treatment Historic Market Size by Application (2017-2022) 5.2 Global Canine Arthritis Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Canine Arthritis Treatment Market Size (2017-2028) 6.2 North America Canine Arthritis Treatment Market Size by Country (2017-2022) 6.3 North America Canine Arthritis Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Canine Arthritis Treatment Market Size (2017-2028) 7.2 Europe Canine Arthritis Treatment Market Size by Country (2017-2022) 7.3 Europe Canine Arthritis Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Canine Arthritis Treatment Market Size (2017-2028) 8.2 Asia-Pacific Canine Arthritis Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Canine Arthritis Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Canine Arthritis Treatment Market Size (2017-2028) 9.2 Latin America Canine Arthritis Treatment Market Size by Country (2017-2022) 9.3 Latin America Canine Arthritis Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Canine Arthritis Treatment Market Size (2017-2028) 10.2 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Elanco (Eli Lilly and Company) 11.1.1 Elanco (Eli Lilly and Company) Company Detail 11.1.2 Elanco (Eli Lilly and Company) Business Overview 11.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Introduction 11.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2017-2022) 11.1.5 Elanco (Eli Lilly and Company) Recent Development 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Company Detail 11.2.2 Boehringer Ingelheim Business Overview 11.2.3 Boehringer Ingelheim Canine Arthritis Treatment Introduction 11.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2017-2022) 11.2.5 Boehringer Ingelheim Recent Development 11.3 Zoetis Inc 11.3.1 Zoetis Inc Company Detail 11.3.2 Zoetis Inc Business Overview 11.3.3 Zoetis Inc Canine Arthritis Treatment Introduction 11.3.4 Zoetis Inc Revenue in Canine Arthritis Treatment Business (2017-2022) 11.3.5 Zoetis Inc Recent Development 11.4 Vetoquinol S.A. 11.4.1 Vetoquinol S.A. Company Detail 11.4.2 Vetoquinol S.A. Business Overview 11.4.3 Vetoquinol S.A. Canine Arthritis Treatment Introduction 11.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2017-2022) 11.4.5 Vetoquinol S.A. Recent Development 11.5 Bayer AG 11.5.1 Bayer AG Company Detail 11.5.2 Bayer AG Business Overview 11.5.3 Bayer AG Canine Arthritis Treatment Introduction 11.5.4 Bayer AG Revenue in Canine Arthritis Treatment Business (2017-2022) 11.5.5 Bayer AG Recent Development 11.6 Aratana Therapeutics Inc 11.6.1 Aratana Therapeutics Inc Company Detail 11.6.2 Aratana Therapeutics Inc Business Overview 11.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Introduction 11.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2017-2022) 11.6.5 Aratana Therapeutics Inc Recent Development 11.7 Norbrook Laboratories Limited 11.7.1 Norbrook Laboratories Limited Company Detail 11.7.2 Norbrook Laboratories Limited Business Overview 11.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Introduction 11.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2017-2022) 11.7.5 Norbrook Laboratories Limited Recent Development 11.8 VetStem Biopharma 11.8.1 VetStem Biopharma Company Detail 11.8.2 VetStem Biopharma Business Overview 11.8.3 VetStem Biopharma Canine Arthritis Treatment Introduction 11.8.4 VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2017-2022) 11.8.5 VetStem Biopharma Recent Development 11.9 Dechra Pharmaceuticals Plc 11.9.1 Dechra Pharmaceuticals Plc Company Detail 11.9.2 Dechra Pharmaceuticals Plc Business Overview 11.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Introduction 11.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2017-2022) 11.9.5 Dechra Pharmaceuticals Plc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Canine Arthritis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs Table 3. Key Players of Opioids Table 4. Global Canine Arthritis Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Canine Arthritis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Canine Arthritis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Canine Arthritis Treatment Market Share by Region (2017-2022) Table 8. Global Canine Arthritis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Canine Arthritis Treatment Market Share by Region (2023-2028) Table 10. Canine Arthritis Treatment Market Trends Table 11. Canine Arthritis Treatment Market Drivers Table 12. Canine Arthritis Treatment Market Challenges Table 13. Canine Arthritis Treatment Market Restraints Table 14. Global Canine Arthritis Treatment Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Canine Arthritis Treatment Market Share by Players (2017-2022) Table 16. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2021) Table 17. Ranking of Global Top Canine Arthritis Treatment Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Canine Arthritis Treatment Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Canine Arthritis Treatment Product Solution and Service Table 21. Date of Enter into Canine Arthritis Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Canine Arthritis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Canine Arthritis Treatment Revenue Market Share by Type (2017-2022) Table 25. Global Canine Arthritis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Canine Arthritis Treatment Revenue Market Share by Type (2023-2028) Table 27. Global Canine Arthritis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Canine Arthritis Treatment Revenue Market Share by Application (2017-2022) Table 29. Global Canine Arthritis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Canine Arthritis Treatment Revenue Market Share by Application (2023-2028) Table 31. North America Canine Arthritis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Canine Arthritis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Canine Arthritis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Canine Arthritis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Canine Arthritis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Canine Arthritis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Elanco (Eli Lilly and Company) Company Detail Table 42. Elanco (Eli Lilly and Company) Business Overview Table 43. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product Table 44. Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 45. Elanco (Eli Lilly and Company) Recent Development Table 46. Boehringer Ingelheim Company Detail Table 47. Boehringer Ingelheim Business Overview Table 48. Boehringer Ingelheim Canine Arthritis Treatment Product Table 49. Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 50. Boehringer Ingelheim Recent Development Table 51. Zoetis Inc Company Detail Table 52. Zoetis Inc Business Overview Table 53. Zoetis Inc Canine Arthritis Treatment Product Table 54. Zoetis Inc Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 55. Zoetis Inc Recent Development Table 56. Vetoquinol S.A. Company Detail Table 57. Vetoquinol S.A. Business Overview Table 58. Vetoquinol S.A. Canine Arthritis Treatment Product Table 59. Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 60. Vetoquinol S.A. Recent Development Table 61. Bayer AG Company Detail Table 62. Bayer AG Business Overview Table 63. Bayer AG Canine Arthritis Treatment Product Table 64. Bayer AG Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 65. Bayer AG Recent Development Table 66. Aratana Therapeutics Inc Company Detail Table 67. Aratana Therapeutics Inc Business Overview Table 68. Aratana Therapeutics Inc Canine Arthritis Treatment Product Table 69. Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 70. Aratana Therapeutics Inc Recent Development Table 71. Norbrook Laboratories Limited Company Detail Table 72. Norbrook Laboratories Limited Business Overview Table 73. Norbrook Laboratories Limited Canine Arthritis Treatment Product Table 74. Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 75. Norbrook Laboratories Limited Recent Development Table 76. VetStem Biopharma Company Detail Table 77. VetStem Biopharma Business Overview Table 78. VetStem Biopharma Canine Arthritis Treatment Product Table 79. VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 80. VetStem Biopharma Recent Development Table 81. Dechra Pharmaceuticals Plc Company Detail Table 82. Dechra Pharmaceuticals Plc Business Overview Table 83. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product Table 84. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2017-2022) & (US$ Million) Table 85. Dechra Pharmaceuticals Plc Recent Development Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Global Canine Arthritis Treatment Market Share by Type: 2021 VS 2028 Figure 2. Non-Steroidal Anti-Inflammatory Drugs Features Figure 3. Opioids Features Figure 4. Global Canine Arthritis Treatment Market Share by Application in 2021 & 2028 Figure 5. Veterinary Hospitals and Clinics Case Studies Figure 6. Drug Stores Case Studies Figure 7. E-commerce Case Studies Figure 8. Canine Arthritis Treatment Report Years Considered Figure 9. Global Canine Arthritis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Canine Arthritis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Canine Arthritis Treatment Market Share by Region: 2021 VS 2028 Figure 12. Global Canine Arthritis Treatment Market Share by Players in 2021 Figure 13. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Canine Arthritis Treatment Revenue in 2021 Figure 15. North America Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Canine Arthritis Treatment Market Share by Country (2017-2028) Figure 17. United States Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Canine Arthritis Treatment Market Share by Country (2017-2028) Figure 21. Germany Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Canine Arthritis Treatment Market Share by Region (2017-2028) Figure 29. China Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Canine Arthritis Treatment Market Share by Country (2017-2028) Figure 37. Mexico Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Canine Arthritis Treatment Market Share by Country (2017-2028) Figure 41. Turkey Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Canine Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Elanco (Eli Lilly and Company) Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 44. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 45. Zoetis Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 46. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 47. Bayer AG Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 48. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 49. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 50. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 51. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Treatment Business (2017-2022) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed
Elanco (Eli Lilly and Company) Boehringer Ingelheim Zoetis Inc Vetoquinol S.A. Bayer AG Aratana Therapeutics Inc Norbrook Laboratories Limited VetStem Biopharma Dechra Pharmaceuticals Plc
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More